Extreme thrombocytosis in response to PEG-ADA: early therapeutic and risk indicator.
Marwaha
V R
VR
School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Italia
D H
DH
Esper
F
F
Hostoffer
R W
RW
D000243:Adenosine Deaminase / Q000009:adverse effects* / Q000172:deficiency / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D016511:Severe Combined Immunodeficiency / Q000175:diagnosis / Q000188:drug therapy*; D013922:Thrombocytosis / Q000139:chemically induced*
D000243:Adenosine Deaminase; C051409:pegademase bovine